Comparison of left versus right atrial myocardium in patients with sinus rhythm or atrial fibrillation - An assessment of mitochondrial function and microRNA expression

Physiological Reports

Volumn 2, Issue 8, 2014, Pages

  Slagsvold, Katrine Hordnes ^a,b   Johnsen, Anne Berit ^a   Rognmo, Øivind ^a   Høydal, Morten ^a   Wisløff, Ulrik ^a   Wahba, Alexander ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Arrhythmia; Atrium; MicroRNA; Mitochondria

Indexed keywords

CREATINE; CYTOCHROME C OXIDASE; MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 10B; MICRORNA 125B; MICRORNA 133A; MICRORNA 133B; MICRORNA 145 5P; MICRORNA 146A; MICRORNA 155; MICRORNA 199A 5P; MICRORNA 208A; MICRORNA 208B; MICRORNA 30B; MICRORNA 92B; MICRORNA 93; UNCLASSIFIED DRUG;

AGED; ARTICLE; ATRIAL FIBRILLATION; BREATHING RATE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEART LEFT ATRIUM MUSCLE; HEART MUSCLE BIOPSY; HEART RIGHT ATRIUM MUSCLE; HEART VALVE SURGERY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SINUS RHYTHM;

EID: 85002933577     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12124     Document Type: Article

References (36)

1. Ausma, J., M. Wijffels, F. Thone, L. Wouters, M. Allessie, and M. Borgers. 1997. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96: 3157-3163.
2. Ausma, J., W. A. Coumans, H. Duimel, G. J. Van der Vusse, M. A. Allessie, and M. Borgers. 2000. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc. Res. 47: 788-796.
3. Caballero, R., M. G. de la Fuente, R. Gomez, A. Barana, I. Amoros, P. Dolz-Gaiton, et al. 2010. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both. J. Am. Coll. Cardiol. 55: 2346-2354.
4. Callis, T. E., K. Pandya, H. Y. Seok, R. H. Tang, M. Tatsuguchi, Z. P. Huang, et al. 2009. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119: 2772-2786.
5. Cooley, N., M. J. Cowley, R. C. Lin, S. Marasco, C. Wong, D. M. Kaye, et al. 2012. Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol. Genomics 44: 211-219.
6. Dirkx, E., M. M. Gladka, L. E. Philippen, A. S. Armand, V. Kinet, S. Leptidis, et al. 2013. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat. Cell Biol. 15: 1282-1293.
7. Fuster, V., L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, et al. 2011. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J. Am. Coll. Cardiol. 57: e101-e198.
8. Go, A. S., E. M. Hylek, K. A. Phillips, Y. Chang, L. E. Henault, J. V. Selby, et al. 2001. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375.
9. Hazarika, S., C. R. Farber, A. O. Dokun, A. N. Pitsillides, T. Wang, R. J. Lye, et al. 2013. MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway. Circulation 127: 1818-1828.
10. Kee, H. J., S. Park, J. S. Kwon, N. Choe, Y. Ahn, H. Kook, et al. 2013. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett. 587: 2385-2392.
11. Kim, Y. M., T. J. Guzik, Y. H. Zhang, M. H. Zhang, H. Kattach, C. Ratnatunga, et al. 2005. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ. Res. 97: 629-636.
12. Kuznetsov, A. V., V. Veksler, F. N. Gellerich, V. Saks, R. Margreiter, and W. S. Kunz. 2008. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat. Protoc. 3: 965-976.
13. Lemieux, H., S. Semsroth, H. Antretter, D. Hofer, and E. Gnaiger. 2011. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int. J. Biochem. Cell Biol. 43: 1729-1738.
14. Li, P., J. Jiao, G. Gao, and B. S. Prabhakar. 2012. Control of mitochondrial activity by miRNAs. J. Cell. Biochem. 113: 1104-1110.
15. Liu, H., H. Qin, G. X. Chen, M. Y. Liang, J. Rong, J. P. Yao, et al. 2014. Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation. J. Transl. Med. 12: 90.
16. Luo, X., H. Zhang, J. Xiao, and Z. Wang. 2010. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell. Physiol. Biochem. 25: 571-586.
17. Mathew, S. T., J. Patel, and S. Joseph. 2009. Atrial fibrillation: mechanistic insights and treatment options. Eur. J. Intern. Med. 20: 672-681.
18. Mihm, M. J., F. Yu, C. A. Carnes, P. J. Reiser, P. M. McCarthy, D. R. Van Wagoner, et al. 2001. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104: 174-180.
19. Montgomery, R. L., T. G. Hullinger, H. M. Semus, B. A. Dickinson, A. G. Seto, J. M. Lynch, et al. 2011. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124: 1537-1547.
20. Morillo, C. A., G. J. Klein, D. L. Jones, and C. M. Guiraudon. 1995. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91: 1588-1595.
21. Muramatsu, F., H. Kidoya, H. Naito, S. Sakimoto, and N. Takakura. 2013. microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 32: 414-421.
22. Natale, A., E. Pisano, S. Beheiry, M. Richey, F. Leonelli, R. Fanelli, et al. 2000. Ablation of right and left atrial premature beats following cardioversion in patients with chronic atrial fibrillation refractory to antiarrhythmic drugs. Am. J. Cardiol. 85: 1372-1375.
23. Neef, S., N. Dybkova, S. Sossalla, K. R. Ort, N. Fluschnik, K. Neumann, et al. 2010. CaMKII-dependent diastolic SR Ca2 + leak and elevated diastolic Ca2 + levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106: 1134-1144.
24. N’Guessan, B., J. Zoll, F. Ribera, E. Ponsot, E. Lampert, R. Ventura-Clapier, et al. 2004. Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles. Mol. Cell. Biochem. 256-257: 267-280.
25. Reilly, S. N., R. Jayaram, K. Nahar, C. Antoniades, S. Verheule, K. M. Channon, et al. 2011. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124: 1107-1117.
26. Saks, V. A., V. I. Veksler, A. V. Kuznetsov, L. Kay, P. Sikk, T. Tiivel, et al. 1998. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol. Cell. Biochem. 184: 81-100.
27. Santulli, G., G. Iaccarino, N. De Luca, B. Trimarco, and G. Condorelli. 2014. Atrial fibrillation and microRNAs. Front. Physiol. 5: 15.
28. Shi, K. H., H. Tao, J. J. Yang, J. X. Wu, S. S. Xu, and H. Y. Zhan. 2013. Role of microRNAs in atrial fibrillation: new insights and perspectives. Cell. Signal. 25: 2079-2084.
29. Slagsvold, K. H., A. B. Johnsen, O. Rognmo, M. A. Hoydal, U. Wisloff, and A. Wahba. 2014. Mitochondrial respiration and microRNA expression in right and left atrium of patients with atrial fibrillation. Physiol. Genomics 46: 505-511.
30. Sripada, L., D. Tomar, and R. Singh. 2012. Mitochondria: one of the destinations of miRNAs. Mitochondrion 12: 593-599.
31. Stefanadis, C., J. Dernellis, and P. Toutouzas. 2001. A clinical appraisal of left atrial function. Eur. Heart J. 22: 22-36.
32. Terentyev, D., A. E. Belevych, R. Terentyeva, M. M. Martin, G. E. Malana, D. E. Kuhn, et al. 2009. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104: 514-521.
33. Veksler, V. I., A. V. Kuznetsov, V. G. Sharov, V. I. Kapelko, and V. A. Saks. 1987. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim. Biophys. Acta 892: 191-196.
34. Wang, Z., Y. Lu, and B. Yang. 2011. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc. Res. 89: 710-721.
35. White, C. W., R. E. Kerber, H. R. Weiss, and M. L. Marcus. 1982. The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ. Res. 51: 205-215.
36. Zoll, J., H. Sanchez, B. N’Guessan, F. Ribera, E. Lampert, X. Bigard, et al. 2002. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J. Physiol. 543: 191-200.